Volume 49, Issue 1, Pages (July 2008)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.

Volume 61, Issue 1, Pages (July 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Volume 43, Issue 3, Pages (September 2005)

Volume 42, Issue 4, Pages (April 2005)

Inflammasomes in liver diseases

Treatment of hepatocellular carcinoma

Volume 67, Issue 2, Pages (August 2017)

Volume 58, Issue 1, Pages (January 2013)

Volume 50, Issue 4, Pages (April 2009)

Radioembolization for hepatocellular carcinoma

Volume 61, Issue 6, Pages (December 2014)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Volume 49, Issue 5, Pages (November 2008)

Jean-Charles Nault, Jessica Zucman-Rossi Journal of Hepatology

Volume 55, Issue 1, Pages (July 2011)

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 68, Issue 4, Pages (April 2018)

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

ART score for retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma: Is it really applicable? Jian Wu, Wei Bai,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

European Association for the Study of the Liver Journal of Hepatology

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Riccardo Lencioni, Fabio Piscaglia, Luigi Bolondi

Treatment of hepatocellular carcinoma

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Why men are at higher risk for hepatocellular carcinoma?

Transcatheter Embolization of an Ovarian Artery Pseudoaneurysm: An Elusive Source of Post-hysterectomy Bleeding T.H. Patel, R.P. Liddell, L.V. Hofmann

Volume 62, Issue 3, Pages (March 2015)

Radioembolization for hepatocellular carcinoma

Genomic risk of hepatitis C-related hepatocellular carcinoma

Autophagy in the liver Journal of Hepatology

Volume 43, Issue 4, Pages (October 2005)

Volume 66, Issue 2, Pages (February 2017)

EASL Clinical Practice Guidelines: Wilson’s disease

Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual

Vascularity of liver tumours and recent advances in Doppler ultrasound

Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma Tao Jiang, Andrew X. Zhu, Dushyant V. Sahani

Volume 50, Issue 4, Pages (April 2009)

Chetana Lim, Chady Salloum, Daniel Azoulay

Immigration and viral hepatitis

Evolution of liver transplantation for hepatocellular carcinoma

Global burden of alcoholic liver diseases

Combined locoregional-immunotherapy for liver cancer

Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma

Volume 63, Issue 1, Pages (July 2015)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

The use of hemospray in portal hypertensive bleeding; a case series

Volume 62, Issue 3, Pages (March 2015)

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence Christian Toso, Gilles Mentha, Pietro.

Digital subtract angiography and lipiodol deposits following embolization in cirrhotic nodules of LIRADS category ≥3 Zhen Kang, Nan Wang, Anhui Xu, Liang.

New trials and results in systemic treatment of HCC

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Genetics of hepatocellular carcinoma: The next generation

Volume 67, Issue 5, Pages (November 2017)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 49, Issue 1, Pages 149-152 (July 2008) Fatal ischemic acute pancreatitis complicating trans-catheter arterial embolization of small hepatocellular carcinoma: Do the risks outweigh the benefits? Luigi Addario, Giovan Giuseppe Di Costanzo, Giovanni Tritto, Enrico Cavaglià, Basilio Angrisani, Antonio Ascione Journal of Hepatology Volume 49, Issue 1, Pages 149-152 (July 2008) DOI: 10.1016/j.jhep.2008.02.021 Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Selective arteriography showing the tumour nodule before (a) and after (b) chemo-embolization. Journal of Hepatology 2008 49, 149-152DOI: (10.1016/j.jhep.2008.02.021) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions

Fig. 2 CT scan performed 3 weeks after TACE. (A) Hyperdense treated HCC nodule in segment VIII with no focal enhancement in different phases. (B) Acute pancreatitis with an about 6cm biloculated pseudocyst (arrowheads) in the head of the pancreas. Journal of Hepatology 2008 49, 149-152DOI: (10.1016/j.jhep.2008.02.021) Copyright © 2008 European Association for the Study of the Liver Terms and Conditions